Physician

Amina Ferheen Basha

According to 2025 Medicare claims, Amina Basha (NPI: 1588195168) practices endocrinology in the Lake County, IL market, with the plurality of this provider's patient population coming from Lake, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60030-2012. Basha is affiliated with the Northwestern Medicine Physician Network ACO (ACO ID: A2620), participating under the MSSP model.

Basha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 229 traditional Medicare patients, billed 547 HCPCS/CPT codes, and received $40,646 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,023 prescription claims across 191 beneficiaries totaling $636,497 in drug costs, led by Ozempic (Semaglutide). DME data shows 69 claims. Open Payments data shows 2 records totaling $55. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $9,266 to $636,497. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	64	92	$9,367
2024	229	547	$40,646

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	31	160	$9,266
2018	60	447	$28,774
2019	75	466	$59,395
2020	40	217	$18,555
2021	20	75	$37,513
2022	55	273	$166,848
2023	95	333	$255,797
2024	191	1,023	$636,497

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	30	69	$19,092

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	45	45	$142
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	111	126	$125
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	25	74	$63
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	46	56	$26
83036	Hemoglobin a1c level	38	43	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	144	6,527	$204,991
Mounjaro	Tirzepatide	118	4,090	$150,470
Jardiance	Empagliflozin	82	5,100	$93,804
Trulicity	Dulaglutide	35	1,512	$47,607
Teriparatide	Teriparatide	11	308	$18,667

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	15	36	$18,666
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	15	22	$404
A4259	Lancets, per box of 100	N	N/R	11	$21

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$55	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amina Ferheen Basha?

Tedicare shows public-source Medicare data for Amina Ferheen Basha (NPI 1588195168), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amina Ferheen Basha have ACO affiliation data?

Amina Ferheen Basha is shown with ACO affiliation data for Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620).

What billing organization is linked to Amina Ferheen Basha?

Amina Ferheen Basha is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Amina Ferheen Basha have Open Payments data?

Amina Ferheen Basha has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.